Radiation Safety Committee (RSC)

A Radiation Safety Committee (RSC) is an institution’s oversight committee responsible for reviewing and approving the research and clinical use of radioactive materials and radiation-producing equipment, and for overseeing the institution’s radiation protection program on an ongoing basis. An RSC exists because the institution holds a radioactive-materials license from the U.S. Nuclear Regulatory Commission (NRC) or from an NRC Agreement State (a state that has taken over regulatory authority for byproduct, source, and special nuclear material under Section 274 of the Atomic Energy Act) — the committee is the internal body the license conditions rely on to authorize individual users and uses under that license. Functionally, an RSC sits alongside an Institutional Biosafety Committee (IBC) and an Institutional Animal Care and Use Committee (IACUC) as one of a research institution’s ancillary regulatory-oversight committees: each reviews a specific hazard or regulated-material category before work involving it can proceed, and each reports on its activity as a condition of the license or assurance that created it.

What makes an oversight body an RSC

A committee qualifies as an RSC when it operates under, and is required by, an NRC or Agreement State radioactive-materials license — not simply because it discusses radiation safety informally. Two regulatory triggers are the ones a research institution most often encounters:

• Broad scope byproduct material licenses. Under 10 CFR 33.13 (Type A specific licenses of broad scope), an applicant must establish an RSC — composed of the Radiation Safety Officer (RSO), a representative of institutional management, and persons trained and experienced in the safe use of radioactive material — along with committee-approved criteria for reviewing and authorizing individual uses and users under the license. A broad scope license lets the RSC itself authorize new users and new uses within NRC-approved limits, rather than requiring the institution to seek an NRC license amendment for every new principal investigator or isotope.
• Medical use licenses with multiple authorized-user types. Under 10 CFR 35.24, a licensee authorized for two or more different types of medical use of byproduct material (spanning the modality subparts of 10 CFR Part 35) must establish an RSC to oversee all such uses. That committee must include an authorized user representing each type of use permitted by the license, the RSO, a representative of the nursing service, and a representative of management who is neither an authorized user nor the RSO.

Institutions with a narrower, “limited scope” license for a single use or user may not be required to convene a formal committee at all — the RSO alone can carry that responsibility — which is why the presence of an RSC is itself a signal that an institution holds a broad scope or multi-modality license, not merely that it possesses radioactive material.

Core functions

• Reviewing and approving individual uses and users. Under a broad scope license, the RSC — not the NRC directly — evaluates each proposed new use of radioactive material or radiation-producing equipment (research protocol, isotope, activity level, procedure) against the committee’s own written criteria, and approves or denies authorization for a given investigator to work under the license.
• Overseeing the Radiation Safety Officer’s program. The RSO carries day-to-day responsibility for the radiation protection program — dosimetry, area surveys, waste handling, and As Low As Reasonably Achievable (ALARA) practice — and the RSC reviews that program’s performance, incident reports, and dose records, typically on a defined periodic cycle (commonly semiannual or annual, per the license’s own commitments).
• Reviewing incidents and enforcing corrective action. The RSC reviews overexposures, contamination events, lost-source incidents, and other reportable occurrences, and has authority to require corrective action or suspend a user’s authorization.
• Maintaining the administrative record the license depends on. Meeting minutes, authorization decisions, and periodic program reviews are part of what an NRC or Agreement State inspector examines to confirm the license’s administrative conditions are being met.

How an RSC differs from an IBC or IACUC

All three are institutional committees created because a specific federal or state regulatory framework requires local, expert review before certain research can proceed — but each answers to a different regulator and reviews a different hazard:

• An Institutional Biosafety Committee (IBC) reviews research involving recombinant or synthetic nucleic acid molecules and other biological hazards, operating under the NIH Guidelines for institutions receiving NIH funding for such work.
• An IACUC reviews and approves the use of live vertebrate animals in research, under the Animal Welfare Act and PHS Policy.
• An RSC reviews the use of radioactive materials and radiation-producing equipment, under an NRC or Agreement State radioactive-materials license.

A single protocol can require sign-off from more than one of these committees at once — for example, an in vivo study using a radiolabeled biological agent in animals could, depending on its design, require RSC, IBC, and IACUC approval before it can proceed. Research administrators coordinating multi-committee protocols typically sequence these approvals rather than assume any one committee’s sign-off covers the others’ jurisdiction.

Frequently asked questions

Does every institution using radioactive materials need an RSC?

No. A formal RSC is a license condition tied specifically to broad scope licenses (10 CFR 33.13) and to medical use licenses authorizing multiple types of use (10 CFR 35.24). An institution holding a narrower, limited scope or single-modality license may operate under RSO oversight alone, without a standing committee, depending on what its specific license requires.

What is an Agreement State, and does it change RSC requirements?

An Agreement State is a state that has entered into an agreement with the NRC under Section 274 of the Atomic Energy Act to regulate byproduct, source, and certain quantities of special nuclear material within its borders in place of the NRC. Most Agreement States adopt requirements compatible with the NRC’s own regulations, so RSC composition and authority requirements are typically substantively similar to the federal rules described above, but an institution in an Agreement State should confirm its specific obligations against that state’s regulations and its own license conditions rather than assume the federal citations apply verbatim.

Who chairs an RSC, and is the Radiation Safety Officer the same as the chair?

Neither 10 CFR 33.13 nor 10 CFR 35.24 mandates a specific chair; institutions set this in their own committee charter or license-approved procedures. The RSO is a required member and often plays the lead operational role, but licenses commonly designate a separate management representative or senior faculty member as chair to preserve a distinction between the RSO’s operational authority and the committee’s oversight role.

Related CASRAI resources: Institutional Biosafety Committee (IBC), IACUC (Institutional Animal Care and Use Committee), and the Research Integrity and Compliance pillar.